Intriguing steroid glycosides for cancer therapy by suppressing the DNA damage response and mTOR/S6K signaling pathways

Bioorg Chem. 2024 Oct:151:107619. doi: 10.1016/j.bioorg.2024.107619. Epub 2024 Jul 9.

Abstract

Two rare 8-hydroxysteroid glycosides (6-7), and their downstream metabolites (1-5) with an unprecedented 6/6/5/5/5-pentacyclic scaffold, together with seven known analogues (8-14) were isolated from the twigs and leaves of Strophanthus divaricatus. Their structures were fully assigned by analysis of the spectroscopic and ECD data, NMR calculations, X-ray crystallographic study, and chemical methods. In addition, the inhibitory effects of 1-14 on liver and lung cancer cell lines were evaluated, and preliminary structure-activity relationship was discussed. Data-independent acquisition (DIA)-based quantitative proteomic analysis and biological verification of H1299 cells suggested that this family of compounds may play an anticancer role by suppressing both DNA damage response (DDR) and mTOR/S6K signaling pathways.

Keywords: Anticancer mechanism; Steroid glycosides; Strophanthus divaricatus; Structural elucidation; Structure–activity relationship.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • DNA Damage* / drug effects
  • Dose-Response Relationship, Drug*
  • Drug Screening Assays, Antitumor*
  • Glycosides* / chemistry
  • Glycosides* / isolation & purification
  • Glycosides* / pharmacology
  • Humans
  • Molecular Structure
  • Ribosomal Protein S6 Kinases / antagonists & inhibitors
  • Ribosomal Protein S6 Kinases / metabolism
  • Signal Transduction* / drug effects
  • Steroids / chemistry
  • Steroids / isolation & purification
  • Steroids / pharmacology
  • Structure-Activity Relationship
  • TOR Serine-Threonine Kinases* / antagonists & inhibitors
  • TOR Serine-Threonine Kinases* / metabolism

Substances

  • TOR Serine-Threonine Kinases
  • Glycosides
  • MTOR protein, human
  • Steroids
  • Ribosomal Protein S6 Kinases
  • Antineoplastic Agents, Phytogenic
  • Antineoplastic Agents